Literature DB >> 14664729

Exploratory studies of Qigong therapy for cancer in China.

Kevin Chen1, Raphael Yeung.   

Abstract

The authors reviewed more than 50 studies of qigong therapy for cancer in China, in 3 categories: clinical studies on cancer patients, in vitro studies on laboratory-prepared cancer cells, and in vivo studies on cancer-infected animals. Most of the clinical studies involved observation of cancer patients' self-practice of qigong. Although no double-blind clinical trials were found among patient studies, many had a control. The qigong groups showed more improvement or had a better survival rate than conventional methods alone. In vitro studies report the inhibitory effect of qi emission on cancer growth, and in vivo studies find that qigong-treated groups have significantly reduced tumor growth or longer survival among cancer-infected animals. However, there is much room for improvement in these studies, and some require replication to verify the findings. Qigong therapy is an area that is often neglected by mainstream medicine and research, but our review strongly suggests that qigong deserves further study as a supplement to conventional cancer treatment.

Entities:  

Mesh:

Year:  2002        PMID: 14664729     DOI: 10.1177/1534735402238187

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  10 in total

Review 1.  Mind-body therapies in integrative oncology.

Authors:  Gary Elkins; William Fisher; Aimee Johnson
Journal:  Curr Treat Options Oncol       Date:  2010-12

2.  Evaluation of biofield treatment dose and distance in a model of cancer cell death.

Authors:  Garret Yount; Shrikant Patil; Umang Dave; Leonardo Alves-dos-Santos; Kimberly Gon; Robert Arauz; Kenneth Rachlin
Journal:  J Altern Complement Med       Date:  2012-06-25       Impact factor: 2.579

Review 3.  Qigong in cancer care: a systematic review and construct analysis of effective Qigong therapy.

Authors:  P J Klein; Roger Schneider; C J Rhoads
Journal:  Support Care Cancer       Date:  2016-04-05       Impact factor: 3.603

4.  A comparison of the effects of medical Qigong and standard exercise therapy on symptoms and quality of life in patients with advanced cancer.

Authors:  B L Vanderbyl; M J Mayer; C Nash; A T Tran; T Windholz; T Swanson; G Kasymjanova; R T Jagoe
Journal:  Support Care Cancer       Date:  2017-01-19       Impact factor: 3.603

5.  Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial.

Authors:  B Oh; P Butow; B Mullan; S Clarke; P Beale; N Pavlakis; E Kothe; L Lam; D Rosenthal
Journal:  Ann Oncol       Date:  2009-10-30       Impact factor: 32.976

Review 6.  A systematic review of the effectiveness of qigong exercise in supportive cancer care.

Authors:  Cecilia L W Chan; Chong-Wen Wang; Rainbow T H Ho; Siu-Man Ng; Jessie S M Chan; Eric T C Ziea; Vivian C W Wong
Journal:  Support Care Cancer       Date:  2012-01-19       Impact factor: 3.603

Review 7.  A Systematic Review of Spiritually Based Interventions and Psychoneuroimmunological Outcomes in Breast Cancer Survivorship.

Authors:  Jennifer M Hulett; Jane M Armer
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

8.  Morning breathing exercises prolong lifespan by improving hyperventilation in people living with respiratory cancer.

Authors:  Wei-Jie Wu; Shan-Huan Wang; Wei Ling; Li-Jun Geng; Xiao-Xi Zhang; Lan Yu; Jun Chen; Jiang-Xi Luo; Hai-Lu Zhao
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

9.  A Methodological Framework for Evaluating the Evidence for Complementary and Alternative Medicine (CAM) for Cancer.

Authors:  Robert Zachariae; Helle Johannessen
Journal:  Cancers (Basel)       Date:  2011-02-23       Impact factor: 6.639

10.  Bioenergy and Breast Cancer: A Report on Tumor Growth and Metastasis.

Authors:  Alice Running; Mark Greenwood; Laura Hildreth; Jade Schmidt
Journal:  Evid Based Complement Alternat Med       Date:  2016-09-05       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.